Scholars Central

Conference abstractPublished 15 Jun 2017

Transcriptomic profiling of personal cell lines as drug response biomarker discovery tool

Authors: David Gurwitz

Tel-Aviv University, Israel

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Genome-wide pharmacogenomic studies for targeted therapies offer the advantage of hypothesis-free search for tentative drug response biomarkers (efficacy and safety). However, they require very large patient cohorts. My talk will present an alternative research approach as prelude to clinical studies in larger cohorts: Genome-wide transcriptomic profiling of a panel of human lymphoblastoid cell lines (LCLs) representing unrelated healthy donors. These cells are personal cell lines that can be obtained from many bio-banks, including our National Laboratory for the Genetics of Israeli Populations (NLGIP) at Tel Aviv. Our approach offers simple and inexpensive discovery of tentative drug response biomarkers and new potential drug targets. I will present our studies on SSRI response biomarkers for precision medicine of major depressive disorder (MDD). We found that lower expression of CHL1 (close homologue of L1), coding for a neuronal cell-adhesion protein implicated in thalamocortical circuitry, is predictive for higher sensitivity to SSRI drugs. This, as well as preliminary findings from clinical studies (to be presented), support the role of CHL1 expression as biomarker for SSRI sensitivity in MDD. These studies also implicate ITGB3 (integrin beta-3), coding for another cell adhesion protein, in the mode of action of SSRI drugs. Further discussed examples will include transcriptomic profiling of LCLs for discovering lithium response biomarkers for precision medicine in bipolar disorder, and for early detection biomarkers for AlzheimerâÂ?Â?s disease.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Molecular and Genetic Medicine.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalMolecular and Genetic Medicine
  • SubjectGenetics & Molecular Biology
  • BylineArticles whose byline prints “David Gurwitz”